Navigation Links
Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients
Date:5/16/2008

24-hour diastolic ambulatory blood pressure and mean seated office systolic and diastolic blood pressure as well as a number of other endpoints.

Investor event at ASH

Pharmacopeia will host a meeting for investors today, Friday, May 16th at 7:00am CDT (8:00am EDT) to review the Phase 2a study results from its PS433540 program, including a presentation by Joel Neutel, M.D., the study's lead investigator. A live webcast and 90-day archive of the presentation can be accessed on the Investors section of the company's website at http://www.pharmacopeia.com.

About PS433540

PS433540 is the first and only blood pressure product candidate in a new class of antihypertensives known as Dual Acting Receptor Antagonists (DARAs). PS433540 is being developed as a potential treatment for hypertension and diabetic nephropathy. PS433540 possesses two clinically validated mechanisms of action in a single molecule. There is preclinical and initial clinical data suggesting that compared to either mechanism alone, simultaneously blocking angiotensin II and endothelin 1 at their respective receptors, AT1 and ETA, may provide an improved treatment option for several cardiovascular diseases. Because PS433540 is highly selective for the AT1 and ETA receptors it is able to block the blood pressure-raising actions of angiotensin and endothelin when they bind to these receptors.

About Pharmacopeia

Pharmacopeia is a clinical development stage biopharmaceutical company dedicated to discovering and developing novel small molecule therapeutics to address significant medical needs. The company has a broad portfolio of clinical and preclinical candidates under development internally or by partners including eight clinical compounds in Phase 2 or Phase 1 development addressing multiple indications including hypertension, diabetic nephropathy, muscle wasting, inflammation and respiratory disease. The compa
'/>"/>

SOURCE Pharmacopeia
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Pharmacopeia Announces Upcoming Late-Breaker Presentation of Phase 2a Results for Its First-in-Class Investigational DARA Compound, PS433540
2. NuRx Pharmaceuticals Doses First Patient in Phase I Clinical Trial of First-in-Class RXR Agonist NRX4204
3. Coley Pharmaceutical Group Diversifies Pipeline with First-in-Class TLR Antagonist for the Treatment of Systemic Lupus Erythematosus
4. NicOx Announces Initiation of First Phase 1 Study of Investigational Nitric Oxide-Donating Agent in Hypertensive Patients by Merck & Co., Inc.
5. Shires Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose
6. Abbotts Phase III Studies of Investigational TriLipix(TM) (ABT-335), in Combination With Statins, Meets Primary Endpoints on Improving LDL, Triglycerides and HDL
7. Study Results Show Investigational Drug, Prasugrel, Cuts Risk of Stent-Related Clots by More than Half Versus Clopidogrel
8. FDA Accepts Investigational New Drug Application for ARI-2243 and a First in Man Clinical Trial Set to Begin During the First Half of 2008
9. Medarex Announces Allowance of Investigational New Drug Applications for Wholly Owned Fully Human Anti-CD19 Antibody, MDX-1342
10. AstraZeneca Completes Enrollment in First Phase III Study of the Investigational Drug Vandetanib (ZACTIMA)(R) in Non-Small Cell Lung Cancer
11. Lexicon Files Investigational New Drug Application for LX2931 as a Potential Treatment for Rheumatoid Arthritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2008)...RNewswire-USNewswire/ -- Older adults who exercise...a greater number of small blood vessels in the bra...nnual meeting of the Radiological Society of North...at the University of North Carolina ( UNC) - Cha...older adults who exercise to brain scans of those ...
(Date:11/27/2008)...f acute lymphoblastic leukemia relapse cases arise...sis , , MEMPHIS, Tenn., Nov. 27 /PRNewswire...Research Hospital have identified distinctive gene...cute lymphoblastic leukemia (ALL) that cause relap...tments for ALL relapse in children and, ultimately...
(Date:11/25/2008)...recovery , , Audio and Web Video Resources ...Clinic News Blog. Please see the bottom of this re...., Nov. 25 A Mayo Clini...think they,re having a stroke -- and as a result -...rsens. The findings appear in the current issue of...
(Date:11/25/2008)...ov. 25 Poniard,Pharmace...al company focused on,innovative oncology therapi...ategic alternatives for its preclinical research p...s resources on the clinical development of picopla...he initial commercialization of,picoplatin in the...
Breaking Medicine Technology:Exercise Helps Prevent Age-Related Brain Changes in Older Adults 2Exercise Helps Prevent Age-Related Brain Changes in Older Adults 3St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 2St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 3Do You Know You're Having a Stroke? 2Do You Know You're Having a Stroke? 3Poniard Pharmaceuticals Announces Management Changes and Focus on Development and Commercialization of Picoplatin 2Poniard Pharmaceuticals Announces Management Changes and Focus on Development and Commercialization of Picoplatin 3Discovery Health is Expecting 21 Season Two of DELIVER ME is Due on Tuesday November 11 at 10 PM ET PT 27276 1Discovery Health is Expecting 21 Season Two of DELIVER ME is Due on Tuesday November 11 at 10 PM ET PT 27276 2Discovery Health is Expecting 21 Season Two of DELIVER ME is Due on Tuesday November 11 at 10 PM ET PT 27276 3Atlanta Area Job Board Launches New Local Job Board to Connect Local Employers and Jobseekers 27273 1Atlanta Area Job Board Launches New Local Job Board to Connect Local Employers and Jobseekers 27273 2Despite peacenik reputation bonobos hunt and eat other primates too 5344 1Despite peacenik reputation bonobos hunt and eat other primates too 5344 2In Room Computers and Wall Mounted Proximity Systems Computer WorkStations Deliver Increased Efficiency 3B Improved Patient Care 8233 1In Room Computers and Wall Mounted Proximity Systems Computer WorkStations Deliver Increased Efficiency 3B Improved Patient Care 8233 2In Room Computers and Wall Mounted Proximity Systems Computer WorkStations Deliver Increased Efficiency 3B Improved Patient Care 8233 3In Room Computers and Wall Mounted Proximity Systems Computer WorkStations Deliver Increased Efficiency 3B Improved Patient Care 8233 4
(Date:12/1/2008)...tute,s cancer registry has found that as many as o...plete radiation treatment following breast-conserv...d to worse outcomes. , Dr. Heather Taffet Gold o...nd that among a nationally representative sample o...d 65 and older, almost 1,300 women experienced del...
(Date:12/1/2008)...ssMutual Retirement Services Division has added tw...fit business. Nonprofit activity has more than tri...n Darby joined MassMutual on December 1 as nonprof...ports to M. Palmer Whitney, national managing dire...t Services Division, who will continue to cover th...
(Date:12/1/2008)...- Senetek PLC,(OTC Bulletin Board: SNKTY), a life...echnologies that target the science of healthy agi...alists in the fields of strategic,development, co...n Zurich,Bern and Geneva has published a Researc...ort, available in the "Investors" section of the C...
(Date:12/1/2008)...antar fasciitis, researchers say , , M...ers say they,ve developed a fast, effective, non-i...nown as plantar fasciitis. , Using a combinatio...by ultrasound, the researchers say their approach ...ondition that afflicts about one million Americans...
Breaking Medicine News(10 mins):Health News:Delays in radiation therapy lead to increased breast cancer recurrence 2Health News:MassMutual Retirement Services Adds Two to Nonprofit Sales Team 2Health News:MassMutual Retirement Services Adds Two to Nonprofit Sales Team 3Health News:New Twist on Treatment of Foot Pain 2Health News:New Twist on Treatment of Foot Pain 3
...ffected states, Tamil Nadu has managed to keep the...que support programme// . The Tamilnadu Aids Init... become a model for other states to emulate. The B...ation's Avahan scheme funds it. Since the HIV vir...
...hing has your full attention you see it vividly. A...miss something important//. Now a new Northwestern...rates. The mystery of how attention improves the p...tion has been a long-time concern of scientists. O...
...ave used a new technique to rapidly detect and pre...oli, without time-consuming// treatments usually r...pray ionization, or DESI, could be used to create ...rs for applications ranging from food safety to ho...
...Niro fears he is going cross-eyed even though his ...ht//. De Niro is now thinking of taking up wearin.... He said: "The optician says there's nothing wro... look in the mirror sometimes. My friend bought me...
Other Medicine News:Health News:Tamil Nadu Checks AIDS Spread 2Health News:Tamil Nadu Checks AIDS Spread 3Health News:Paying Attention Sets Off Symphony of Cell Synchronization 2Health News:New Technique to Identify Bacteria for Food Safety 2Health News:New Technique to Identify Bacteria for Food Safety 3
The generously sized STERILE VIEW Monk Hood from DePuy provides splash protection in the chin and neck areas from body fluids and liquids. Shoulder cut outs and ties ensure a comfortable fit. This pr
...he Nidek NM-200D's compact, lightweight body with ...more options to treat more patients, more comforta... operation and functionality for image capture, pr...ge data to the compact flash card. Through USB int...
PacePath is a comprehensive anatomic pathology software system that is the culmination of more than five years of development and testing by leading industry experts.
...abNet LIS is a Windows NT client server system tha...ity, power and high-speed volume required to meet ...ndustry experts, LabNet is structured to make gene...fective as possible. Our system can upload lab act...
Medicine Products: